Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.
about
Comparative analysis and integrative classification of NCI60 cell lines and primary tumors using gene expression profiling dataAn integrative genomic and proteomic approach to chemosensitivity predictionDigitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cellsHLA class I and II genotype of the NCI-60 cell linesApplication of protein lysate microarrays to molecular marker verification and quantificationUsing CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60In vitro human cell line models to predict clinical response to anticancer drugsUsing drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancerSearching for IRESUsing Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer TherapyReverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical UseProtein pathway activation mapping reveals molecular networks associated with antiestrogen resistance in breast cancer cell linesBiomarkers in cancer staging, prognosis and treatment selectionReverse phase protein microarrays advance to use in clinical trialsIntegrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line setPharmacogenomic discovery using cell-based modelsAberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parametersIdentification of a predominant co-regulation among kinetochore genes, prospective regulatory elements, and association with genomic instabilityNCI-60 whole exome sequencing and pharmacological CellMiner analysesHigh resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMinerProtein quantitative trait loci identify novel candidates modulating cellular response to chemotherapySelf-Organizing Feature Maps Identify Proteins Critical to Learning in a Mouse Model of Down SyndromeDevelopment of a Drug-Response Modeling Framework to Identify Cell Line Derived Translational Biomarkers That Can Predict Treatment Outcome to Erlotinib or SorafenibIntegrated analysis of transcriptomic and proteomic dataMinireview: progress and challenges in proteomics data management, sharing, and integrationProteomics and mass spectrometry for cancer biomarker discoveryComparison of global versus epidermal growth factor receptor pathway profiling for prediction of lapatinib sensitivity in bladder cancer.Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.TCPA: a resource for cancer functional proteomics dataGene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages--strategies for data mining in support of therapeutic studies.Spatial normalization of reverse phase protein array data.Modified SuperCurve Method for Analysis of Reverse-Phase Protein Array Data.Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel.PARE: a tool for comparing protein abundance and mRNA expression data.Handling missing rows in multi-omics data integration: multiple imputation in multiple factor analysis framework.Mass spectrometry in diagnostic oncoproteomics.AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies.Proteomics of breast cancer: principles and potential clinical applications.Display technologies: application for the discovery of drug and gene delivery agents.Direct tissue proteomics in human diseases: potential applications to melanoma research.
P2860
Q21266587-4F1CB0ED-0719-4FF9-A205-515732821EB2Q23909225-1B4D95A8-6F46-4147-91A4-3059E6F2CA43Q24562089-DE3ED761-8AA1-45C6-B003-1E29097A8E50Q24805062-8C1A48EA-EDAD-42CC-9153-AF39B499577AQ25257533-75519AA5-3F3A-42CE-AA51-0B92C827E48AQ26826831-9590DE7B-F4FE-4758-AD3F-0A29C37D517AQ27000665-3C38E7B5-DF89-4492-9FFA-5A560FBE0218Q27320602-CAA9C583-72A7-4480-A7B9-1F05D7FCEF4EQ27477494-0273CD3A-8AFB-41B4-8D06-FDB0BF9AE97BQ28076097-C7FD1DB8-6152-418B-A389-3666F77C273AQ28083256-1F581557-9679-44A8-84CB-F50708635BDEQ28259553-A499E79D-BEF1-462C-A15A-AD55981DB028Q28278305-DA0F7D84-EE65-4955-B6F4-9B1C463EA3EAQ28384553-6D813BBB-A866-4FF4-9D4C-F0149C3441E2Q28389579-98BF1100-B0F3-4CD7-809E-BC8899F8A235Q28392982-B67C328A-B3BF-4420-9F19-D02B682383FAQ28396602-F302A05A-2172-43F6-AEE1-6E37F90A2778Q28477417-66CF5FF4-27E7-496E-B505-BE8FBD97D588Q28540834-F0857083-E364-4450-BC36-C74C4B9142B0Q28541555-3FD40814-BB69-4A51-B8FC-54F27A46FBD7Q28541831-B8531EF4-BE93-4F20-9DCA-2A7BE8D31E57Q28545764-D72FE9E3-D865-4B2E-9BC6-07560BDEF05FQ28548663-F6727272-D468-49E0-952B-9DE35968FF85Q28707991-09A0FCCE-1A1C-4958-8498-64F219F4A651Q28727478-6F9605EB-58FA-4125-8A05-64F76BA7FFA5Q28766969-27A4D665-947F-4059-9672-191743A0627AQ30438089-A10C547F-5DD4-4A2D-A21C-0556548DBA5FQ30446755-A21D00E8-AE84-4818-BAB1-5E6FCE53D09EQ30666936-BA9B54A3-E640-42C6-A59F-B95906C421ACQ30828205-5B8676FE-4CC7-4ED7-BA06-CA173DFD21CAQ30877911-05AC452C-AB13-41FA-B9F7-891573766E9EQ30967609-F02A4B4E-3EDF-46BF-AF09-C163EFB8E42BQ31038779-BDEA6AF7-CED5-4002-AA3E-0DEAA7E660A1Q31122575-3F2D1953-4CDC-4C99-B065-B8943CB59D80Q31135471-F415F8BF-F133-41C2-B57F-BED51A113DEAQ33224210-C56DDBF4-7732-48D0-9F16-C01A573A51DBQ33239131-16AC5A76-A5AB-4C0A-A7EF-76DB8E079142Q33245053-40C0C67A-5EBB-43B4-BCB3-2DA6F7E734D9Q33264491-5C0ACF5B-51DF-48B7-8596-B207780863A7Q33340658-52C93AB5-95AE-4550-BF73-389CAEC685B8
P2860
Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Proteomic profiling of the NCI ...... erse-phase lysate microarrays.
@ast
Proteomic profiling of the NCI ...... erse-phase lysate microarrays.
@en
type
label
Proteomic profiling of the NCI ...... erse-phase lysate microarrays.
@ast
Proteomic profiling of the NCI ...... erse-phase lysate microarrays.
@en
prefLabel
Proteomic profiling of the NCI ...... erse-phase lysate microarrays.
@ast
Proteomic profiling of the NCI ...... erse-phase lysate microarrays.
@en
P2093
P2860
P50
P356
P1476
Proteomic profiling of the NCI ...... erse-phase lysate microarrays.
@en
P2093
Emanuel Petricoin
Hosein Kouros-Mehr
John N Weinstein
Lance A Liotta
Lu Charboneau
Lynn Young
Mark Waltham
Peter J Munson
Satoshi Nishizuka
P2860
P304
14229-14234
P356
10.1073/PNAS.2331323100
P407
P577
2003-11-17T00:00:00Z